FDA reviewing cancer risk with diabetes pill Actos
Links shared publicly online about this topic.
- 214total visits
FDA reviewing cancer risk with diabetes pill Actos
View full resource at huffingtonpost.com
Tags: Diabetes, Diabetes Type 2 Medication, Diabetes Medication, Cancer, Drug, FDA, Actos
Most Recently Shared on June 16, 2011 at 5:18 pm By:
An interesting article on Actos: http://fb.me/NEHGd7pa
Takeda's Actos diabetes pill needs new cancer-risk warning, Europe says | The Japan Times Online
search.japantimes.co.jp — “Takeda Pharmaceutical Co.'s Actos diabetes drug may be kept on the market with new warnings, the European Medicines Agency said after reviewing research showing the drug carried a slightly increased risk of bladder cancer.” View full resource at search.japantimes.co.jp
Most Recently Shared on July 23, 2011 at 12:52 am By:
Takeda's Actos diabetes pill needs new cancer-risk warning, Europe says: Takeda Pharmaceutical Co.'s Actos diabe... http://bit.ly/nk7vkg
Medical News: FDA Warns of Bladder Cancer Risk With Actos - in Primary Care, Diabetes from MedPage Today
t.co — “Patients taking pioglitazone (Actos) for more than a year may have an increased risk of bladder cancer, according to an FDA interim review of an ongoing study. The warning comes just days after two Eu” View full resource at t.co
Most Recently Shared on June 16, 2011 at 4:41 pm By:
Medical News: FDA Warns of Bladder Cancer Risk With Actos~ http://t.co/94nRiwM.
Medical News: FDA Warns of Bladder Cancer Risk With Actos - in Primary Care, Diabetes from MedPage Today
medpagetoday.com — “Patients taking pioglitazone (Actos) for more than a year may have an increased risk of bladder cancer, according to an FDA interim review of an ongoing study. The warning comes just days after two Eu” View full resource at medpagetoday.com
Most Recently Shared on June 16, 2011 at 2:50 pm By:
The Kidney Group Physician Group and Nephrology
FDA warns of bladder cancer risk with Actos. #diabetes http://t.co/Gz7EeII
Medical News: FDA Warns of Bladder Cancer Risk With Actos - in Primary Care, Diabetes from MedPage Today
medpagetoday.com — “Patients taking pioglitazone (Actos) for more than a year may have an increased risk of bladder cancer, according to an FDA interim review of an ongoing study. The warning comes just days after two Eu” View full resource at medpagetoday.com
Most Recently Shared on June 15, 2011 at 10:12 pm By:
Days after France & Germany ban Actos because of bladder cancer risk, FDA issues warning (via @health_tweets) http://dld.bz/ad38X #diabetes
Medical News: FDA Warns of Bladder Cancer Risk With Actos - in Primary Care, Diabetes from MedPage Today
medpagetoday.com — “Patients taking pioglitazone (Actos) for more than a year may have an increased risk of bladder cancer, according to an FDA interim review of an ongoing study. The warning comes just days after two Eu” View full resource at medpagetoday.com
Most Recently Shared on June 15, 2011 at 9:51 pm By:
FDA Warns of Bladder Cancer Risk With Actos http://bit.ly/ihL6bo
FDA publishes list of drugs under safety review - Related Stories - AAP SmartBrief
smartbrief.com — “The FDA published its quarterly list of medicines under early review for potential safety risks. Included are Sanofi-Aventis' heart drug Multaq and Takeda Pharmaceutical's diabetes pill Actos. Being on the list "does not mean that FDA is suggesting that health care providers should not prescribe the” View full resource at smartbrief.com
Most Recently Shared on February 2, 2011 at 3:26 am By:
Clara Song Pediatrician, Physician, and Doctor
FDA publishes list of drugs under safety review http://sbne.ws/r/6E5j
Diabetes Pill Actos May Pose Cancer Risk | Diabetes | Type 2 Diabetes | Diabetes Mellitus | Keyvive.com
keyvive.com — “Diabetes Pill Actos May Pose Cancer Risk | Diabetes | Type 2 Diabetes | Diabetes Mellitus | Keyvive.com” View full resource at keyvive.com
Most Recently Shared on September 20, 2010 at 9:36 pm By:
Diabetes Pill Actos May Pose Cancer Risk: The Food and Drug Administration is reviewing data… http://goo.gl/fb/ST4qM
FDA studies risk of cancer with diabetes pill Actos - The Boston Globe
healthcare.tweetmeme.com — “All the news on healthcare” View full resource at healthcare.tweetmeme.com
Most Recently Shared on September 18, 2010 at 9:25 pm By:
Healthcare TweetMeme Health Social Media
FDA studies risk of cancer with diabetes pill Actos - The Boston Globe http://retwt.me/1OPJs (via @GlobeHealth)
Diabetes Drug Actos (pioglitazone) Review Initiated To Determine Possible Bladder Cancer Link - QualityPoint Technologies
qualitypointtech.net — “Actos (pioglitazone), a diabetes medication is being reviewed by the FDA (Food and Drug Administration) after it received a long-term observational study which evaluated the risk of bladder cancer. The preliminary results of the 10-year observational long-term study are based on five-year data gathered by Takeda Pharmaceuticals North America Inc., San Diego. Pioglitazone is used along with diet and exercise to control blood sugar or improve control of blood sugar in patients with Type 2 Diabetes” View full resource at qualitypointtech.net
Most Recently Shared on September 18, 2010 at 8:49 pm By:
Diabetes Drug Actos (pioglitazone) Review Initiated To Determine Possible Bladder Cancer Link: Actos (pioglitazone... http://bit.ly/aOHwmC
Diabetes Pill Actos May Pose Cancer Risk - Topix
topix.com — “Diabetes Pill Actos May Pose Cancer Risk - Topix” View full resource at topix.com
Most Recently Shared on September 18, 2010 at 4:34 am By:
Diabetes Pill Actos May Pose Cancer Risk: The Food and Drug Administration is reviewing data suggesting a possible... http://bit.ly/aU79PM
FDA reviews Actos drug for bladder cancer risk
news-medical.net — “The U.S. Food and Drug Administration today announced it has begun a safety review of the diabetes drug Actos (pioglitazone), after receiving preliminary results from a long-term observational study designed to evaluate the risk of bladder cancer associated with use of this drug.” View full resource at news-medical.net
Most Recently Shared on September 18, 2010 at 4:29 am By:
FDA reviews Actos drug for bladder cancer risk: The U.S. Food and Drug Administration today announced it has begun... http://bit.ly/bKwtuu
FDA reviewing cancer risk with diabetes pill Actos | Diabetes | Type 2 Diabetes | Diabetes Mellitus | Keyvive.com
keyvive.com — “FDA reviewing cancer risk with diabetes pill Actos | Diabetes | Type 2 Diabetes | Diabetes Mellitus | Keyvive.com” View full resource at keyvive.com
Most Recently Shared on September 17, 2010 at 10:53 pm By:
FDA reviewing cancer risk with diabetes pill Actos: The Food and Drug Administration is… http://goo.gl/fb/EcE7C
FDA reviews diabetes drug Actos – The Chart - CNN.com Blogs
pagingdrgupta.blogs.cnn.com — “Another diabetes drug is under the Food and Drug Administration's microscope amid safety concerns. On Friday, the agency announced preliminary five-year data shows Actoscan increase the risk of bladder cancer in patients using the drug long-term.” View full resource at pagingdrgupta.blogs.cnn.com
Most Recently Shared on September 17, 2010 at 9:02 pm By:
Global Healing Ctr. Health Business
FDA reviews diabetes drug Actos http://bit.ly/aIM7H8 via: @sanjayguptaCNN
FDA probes risks of bladder cancer with diabetes pill Actos, competitor to Glaxo's Avandia | StarTribune.com
startribune.com — “FDA probes risks of bladder cancer with diabetes pill Actos, competitor to Glaxo's Avandia | StarTribune.com” View full resource at startribune.com
Most Recently Shared on September 17, 2010 at 7:12 pm By:
FDA probes risks of bladder cancer with diabetes pill Actos, competitor to Glaxo's Avandia: http://bit.ly/ap7ybQ
Advertisement
